Histiocytosis following T-acute lymphoblastic leukemia: A BFM study

References

• Pui C, Behm F, Raimondi S, Dodge R K, George S L, Rivera G K, et al. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. New England Journal of Medicine 1989; 321: 136
   PubMed Web of Science ®Google Scholar
• Egeler R M, Neglia J P, Aricò M, Favara B E, Heitger A, Nesbit M E. Acute leukemia in association with Langerhans cell histiocytosis. Medical Pediatric Oncology 1994; 23: 81–85
   PubMedGoogle Scholar
• Skoog D, Feagler J. T cell acute lymphocytic leukemia terminating as malignant histiocytosis. American Journal of Medicine 1978; 64: 678–682
   PubMed Web of Science ®Google Scholar
• Starkie C M, Kenny M W, Mann J R, Cameron A H, Hill F G. Histiocytic medullary reticulosis following acute lymphoblastic leukemia. Cancer 1981; 47: 537–544
   PubMed Web of Science ®Google Scholar
• Egeler R, Neglia J, Puccetti D, Brennan C, Nesbit M. Association of Langerhans cell histiocytosis with malignant neoplasms. Cancer 1993; 71: 865
   PubMed Web of Science ®Google Scholar
• Aricò M, Comelli A, Bossi G, Raiteri E, Piombo M, Egeler R. Langerhans cell histiocytosis and acute leukemia: unusual association in two cases. Medical Pediatric Oncology 1993; 21: 271
   PubMedGoogle Scholar
• Horibe K, Matsushita T, Numata S, Miyajima Y, Katayama I, Kitabyashi T, et al. Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis. Cancer 1993; 72: 3723
   PubMed Web of Science ®Google Scholar
• Tatsumi T, Shimazaki C, Araki S I, Sudo Y, Yamagata N, Ashihara E, et al. Philadelphia chromosome-positive acute lymphoblastic leukemia after therapy for Langerhans cell histiocytosis. American Journal of Hematology 1997; 54: 88
   PubMed Web of Science ®Google Scholar
• Falini B, Pileri S, De Solas I, Martelli M F, Mason D Y, Delsol G, et al. Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood 1990; 75: 434–444
   PubMed Web of Science ®Google Scholar
• Sullivan J, Woda B. Lymphohistiocytic disorders. Hematology of infancy and childhood, D Nathan, F Oski. Saunders, Philadelphia, PA 1993; 1354
   Google Scholar
• Cline M. Histiocytes and histiocytosis. Blood 1994; 84: 2840–2853
   PubMed Web of Science ®Google Scholar
• Miller D, Ladisch S. Disorders of the spleen and the monocyte-macrophage system. Blood diseases of infancy and childhood, D Miller, R Baehner. Mosby, St. Louis, MO 1995; 805
   Google Scholar
• Imashuku S. Hemophagocytic syndrome. Japanese Journal of Pediatric Hematology 1991; 5: 349
   Google Scholar
• Henter J I, Elinder G, Öst A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Seminars in Oncology 1991; 18: 29–33
   PubMed Web of Science ®Google Scholar
• Favara B E, Jaffe R, Egeler R M. Macrophage activation and hemophagocytic syndrome in langerhans cell histiocytosis: report of 30 cases. Pediatric Developments in Pathology 2002; 5: 130–140
   PubMed Web of Science ®Google Scholar
• Ohga S, Matsuzaki A, Nishizaki M, Nagashima T, Kai T, Suda M, Ueda K. Inflammatory cytokines in virus-associated hemophagocytic syndrome. Interferon-gamma as a sensitive indicator of disease activity. American Journal of Pediatric Hematology and Oncology 1993; 15: 291–298
   PubMedGoogle Scholar
• Akashi K, Hayashi S, Gondo H, Mizuno S, Harada M, Tamura K, et al. Involvement of interferon-gamma and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults. British Journal of Haematology 1994; 87: 243–250
   PubMed Web of Science ®Google Scholar
• Riddell S, Greenberg P. Principles for adoptive T cell therapy of human viral diseases. Annual Review of Immunology 1995; 13: 545–586
   PubMed Web of Science ®Google Scholar
• Stephan J, Donadieu J, Ledeist F, Blanche S, Griscelli C, Fischer A. Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A. Blood 1993; 82: 2319–2323
   PubMed Web of Science ®Google Scholar
• Watson H, Goulden N, Manson L, McDermid G, Gray J, Parker A. Virus-associated haemophagocytic syndrome: further evidence for a T-cell mediated disorder. British Journal of Haematology 1994; 86: 213–215
   PubMed Web of Science ®Google Scholar
• Oyama Y, Amano T, Hirakawa S, Hironaka K, Suzuki S, Ota Z. Haemophagocytic syndrome treated with cyclosporin A: a T cell disorder?. British Journal of Haematology 1989; 73: 276–278
   PubMed Web of Science ®Google Scholar
• Osugi Y, Hara J, Tagawa S, Takai K, Hosoi G, Matsuda Y, et al. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 1997; 89: 4100–4103
   PubMed Web of Science ®Google Scholar
• Gadner H, Grois N. Langerhans cell histiocytosis. Cancer in children: Clinical management, P Voute, C Kalifa, A Barrett. Oxford University Press, OxfordUK 1998; 154–169
   Google Scholar
• Mami N, Mohty M, Chambost H, Gaugler B, Olive D. Blood dendritic cells in patients with acute lymphoblastic leukaemia. British Journal of Haematology 2004; 126: 77–80
   PubMed Web of Science ®Google Scholar
• Pullen J, Shuster J J, Link M, Borowitz M, Amylon M, Carroll A J, et al. Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study. Leukemia 1999; 13: 1696–1707
   PubMed Web of Science ®Google Scholar
• Shuster J J, Falletta J M, Pullen D J, Crist W M, Humphrey G B, Dowell B L, et al. Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 1990; 75: 166–173
   PubMed Web of Science ®Google Scholar
• Crist W, Shuster J, Look T, Borowitz M, Behm F, Bowman P, et al. Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. ThePediatric Oncology Group. Leukemia 1992 + ADs 1992; 2: 162–166
   Google Scholar
• Pieters R, den Boer M L, Durian M, Janka G, Schmiegelow K, Kaspers G J, et al. Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia—implications for treatment of infants. Leukemia 1998; 12: 1344–1348
   PubMed Web of Science ®Google Scholar
• Kaspers G J, Pieters R, Van Zantwijk C H, Van Wering E R, Veerman A J. Clinical and cell biological features related to cellular drug resistance of childhood acute lymphoblastic leukemia cells. Leukemia & Lymphoma 1995; 19: 407–416
   PubMed Web of Science ®Google Scholar
• Imashuku S, Hibi S, Tabata Y, Sako M, Sekine Y, Hirayama K, et al. Biomarker and morphological characteristics of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis. Medical Pediatric Oncology 1998; 31: 131–137
   PubMedGoogle Scholar
• Janka G, Imashuku S, Elinder G, Schneider M, Henter J -I. Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Langerhans cell histiocytosis, R M Egeler, G J D'Angio. W. B. Saunders Company, PhiladelphiaPA 1998; 435–444
   Google Scholar
• Henter J, Samuelsson-Horne A, Arico M, Egeler R M, Elinder G, Filipovich A H, , Histiocyte Society, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002; 100: 2367–2373
   PubMed Web of Science ®Google Scholar